Convex vs Insilico Medicine
Side-by-side comparison to help you choose the best tool.
Convex
freemiumConvex is a fullstack TypeScript cloud backend for reactive applications, providing a database, serverless functions, file storage, and real-time subscriptions in one platform. Its developer-friendly approach with full TypeScript, automatic query caching, and built-in vector search make it popular for building AI applications with real-time reactivity.
Insilico Medicine
paidInsilico Medicine is an AI drug discovery company using generative AI to design novel drug candidates, predict clinical trial outcomes, and accelerate pharmaceutical R&D. The company uses its Pharma.AI platform to discover new drug targets and generate novel molecular structures for diseases with unmet medical need. It has capable multiple AI-designed drugs into clinical trials, demonstrating the potential of AI in full drug discovery.
| Feature | Convex | Insilico Medicine |
|---|---|---|
| Pricing | freemium | paid |
| Category | - | - |
| Rating | 4.4 | 4.5 |
| Best For | TypeScript developers building real-time AI applications who want a backend that handles database, functions, and vector search in one reactive system | Pharmaceutical companies seeking to accelerate drug discovery and reduce R&D costs with generative AI |
| Views | 2 | 3 |
Pros
- End-to-end TypeScript with automatic type safety
- Real-time reactivity without polling
- Built-in vector search for AI apps
Cons
- JavaScript/TypeScript only
- Less flexible than Supabase for SQL power users
Pros
- Multiple AI-designed drugs in clinical trials
- End-to-end AI drug discovery capability
- Significantly faster than traditional methods
Cons
- Enterprise-only partnerships
- Long timelines still involved in clinical validation
- Fullstack TypeScript backend
- Real-time reactive queries
- Built-in vector search
- Serverless functions
- Automatic caching
- Generative AI drug design
- Target identification
- Clinical trial outcome prediction
- Molecular property optimisation
- End-to-end drug discovery pipeline